Medical University of South Carolina (MUSC) researchers have found a new way to potentially inhibit colorectal tumor growth. The Problem While the emergence of precision medicine and immunotherapy has greatly improved outcomes for patients with colorectal cancer, new...
Dr. O’Neil has been actively involved with the study of semaglutide as a potential treatment for adults with obesity. As a lead investigator, last year he presented results of a Phase 2 Novo Nordisk semaglutide obesity study at the Endocrine Society’s annual meeting...
Medical University of South Carolina (MUSC), a NCI-designated Cancer Center strives to bring its patients cutting edge cancer treatment options. They recently provided a link to featured trials available at the center. Select the link below to review the showcased...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
